It is noteworthy that more than half of the melanomas evidence BRAF V600 mutations (Ascierto et al., 2012) with ∼25% of neuroblastoma RAS viral oncogene homolog (NRAS) gene mutations (Rajkumar and Watson, 2016). This evidence concerns the gene BRAF and melanoma.